Ignite Creation Date:
2024-05-06 @ 5:47 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05437224
Status:
COMPLETED
Last Update Posted:
2022-06-29
First Post:
2022-06-24
Brief Title:
Efficacy and Safety Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension
Sponsor:
RenJi Hospital
Organization:
RenJi Hospital
Organization Data
Organization:
RenJi Hospital
Class:
OTHER
Study ID:
AMBEL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
RenJi Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Shanghai Zhongshan Hospital | OTHER |
| The First Affiliated Hospital with Nanjing Medical University | OTHER |
| Shanghai Pulmonary Hospital Shanghai China | OTHER |
| Xinqiao Hospital of Chongqing | OTHER |
| The Affiliated Hospital of Qingdao University | OTHER |
| First Affiliated Hospital of Chongqing Medical University | OTHER |
| Wuhan Asia Heart Hospital | OTHER |